ORCID Profile
0000-0003-1357-8277
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: SAGE Publications
Date: 19-12-2022
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 15-12-2023
Publisher: Cureus, Inc.
Date: 17-03-2022
DOI: 10.7759/CUREUS.23260
Publisher: Cureus, Inc.
Date: 17-08-2022
DOI: 10.7759/CUREUS.28095
Publisher: Cureus, Inc.
Date: 08-10-2022
DOI: 10.7759/CUREUS.30075
Publisher: Cureus, Inc.
Date: 03-11-2021
DOI: 10.7759/CUREUS.19243
Publisher: IEEE
Date: 2010
Publisher: IEEE
Date: 04-2010
Publisher: Cureus, Inc.
Date: 16-11-2021
DOI: 10.7759/CUREUS.19620
Publisher: Cureus, Inc.
Date: 22-12-2021
DOI: 10.7759/CUREUS.20601
Publisher: Cureus, Inc.
Date: 08-12-2021
DOI: 10.7759/CUREUS.20269
Publisher: Informa UK Limited
Date: 04-2022
DOI: 10.2147/JPR.S344191
Publisher: Cureus, Inc.
Date: 02-12-2021
DOI: 10.7759/CUREUS.20108
Publisher: Cureus, Inc.
Date: 29-12-2021
DOI: 10.7759/CUREUS.20802
Publisher: Cureus, Inc.
Date: 26-08-2022
DOI: 10.7759/CUREUS.28429
Publisher: IEEE
Date: 11-2010
Publisher: Cureus, Inc.
Date: 17-05-2022
DOI: 10.7759/CUREUS.25079
Publisher: Georg Thieme Verlag KG
Date: 27-11-2021
Abstract: Left ventricular assist devices (LVAD) are mechanical pumps that have become a standard treatment for end-stage heart failure. As patients with LVAD are living longer, the number of noncardiac surgeries performed in these patients is rising. However, these patients present a unique set of risk factors, some of which include acquired coagulopathies, anticoagulation status, and hemodynamic instability. Thus, performing noncardiac surgeries in patients with an LVAD requires a precise and complex surgical strategy with optimal communication among the surgical team. Therefore, knowledge of best perioperative approaches for patients with LVAD is urgently needed. Here, we present a detailed perioperative surgical approach in the case of a brain tumor resection for a 62-year-old patient with an LVAD whose course was complicated with a brain hematoma. Critical details include key aspects of monitoring patient hemodynamic stability and handling of anesthesia, patient positioning, and antiplatelet and anticoagulation drug therapy. This case highlights the importance for anesthesiologists to be well informed about perioperative LVAD management, as well as common complications that they may encounter.
Publisher: Cureus, Inc.
Date: 12-2021
DOI: 10.7759/CUREUS.20068
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 15-12-2023
Publisher: IEEE
Date: 06-2010
Publisher: Springer Science and Business Media LLC
Date: 29-05-2023
DOI: 10.7759/CUREUS.39636
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 09-2023
Publisher: IEEE
Date: 06-2010
Publisher: Authorea, Inc.
Date: 13-02-2023
Publisher: Authorea, Inc.
Date: 25-07-2023
Publisher: BMJ
Date: 10-2021
Abstract: Previous reports have described non-ischaemic cardiomyopathy related to a variety of autoimmune diseases. However, very few case reports describe Sjögren disease as a contributing factor to cardiomyopathy. We report the case of a 69-year-old woman with a history of Sjögren disease who presented with cardiogenic shock. Laboratory testing and cardiac MRI revealing apical septal late gadolinium enhancement were consistent with an autoimmune aetiology. After ruling out ischaemic, infectious and other possible causes, the patient’s clinical presentation was thought to be related to underlying Sjögren disease. She was treated with intravenous steroids and evidence-based heart failure therapy, but she eventually died after having declined heart transplantation. Given the rarity of Sjögren disease, no diagnostic criteria or standard treatment has been established for cardiomyopathy related to this disease. Diagnosis should be considered in patients who show evidence of autoimmune processes after other possible causes are ruled out.
Publisher: Cureus, Inc.
Date: 28-07-2022
DOI: 10.7759/CUREUS.27409
Publisher: IEEE
Date: 02-2010
Publisher: Cureus, Inc.
Date: 16-07-2022
DOI: 10.7759/CUREUS.26911
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 11-12-2021
Publisher: Cureus, Inc.
Date: 28-02-2022
DOI: 10.7759/CUREUS.22699
Location: United States of America
Location: United States of America
No related grants have been discovered for Mohamed Fayed.